Results 161 to 170 of about 690,170 (210)
Some of the next articles are maybe not open access.
Carcinoid heart disease: a potentially fatal complication of carcinoid syndrome
BMJ Case Reports, 2023Carcinoid heart disease is a unique and serious cardiac complication of the neuroendocrine tumour that affects the right side of the heart, especially the tricuspid and pulmonic valves, eventually causing right heart failure. We present a middle-aged man
Mustafa Bdiwi +6 more
semanticscholar +1 more source
Carcinoid Heart Disease: a Review
Current Oncology Reports, 2021The development of carcinoid heart disease (CHD) is a fibrotic complication of neuroendocrine neoplasms (NEN) which is associated with a poor prognosis. This review aims to summarise the clinical features, investigations and management of this condition.CHD can affect up to 50% of NET patients with carcinoid syndrome.
Faidon-Marios Laskaratos +2 more
openaire +3 more sources
International Journal of Cardiology, 2008
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
Clinical Nuclear Medicine
Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome.
C. Laschinsky +4 more
semanticscholar +1 more source
Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome.
C. Laschinsky +4 more
semanticscholar +1 more source
Circulation, 2023
Carcinoid tumors are neuroendocrine neoplasms that secrete vasoactive substances, primarily serotonin, and have an incidence of approximately 2 in 100,000 people.
Jordan Troy +4 more
semanticscholar +1 more source
Carcinoid tumors are neuroendocrine neoplasms that secrete vasoactive substances, primarily serotonin, and have an incidence of approximately 2 in 100,000 people.
Jordan Troy +4 more
semanticscholar +1 more source
Two- and Three-dimensional Imaging in Carcinoid Heart Disease
Journal of The Indian Academy of Echocardiography & Cardiovascular ImagingA 70-year-old male presented with a history of pedal edema, abdominal distension, and dyspnea on exertion New York Heart Association Class III for cardiology evaluation.
Abhiman B Shetty +2 more
semanticscholar +1 more source
Circulation, 2023
Background: Patients with carcinoid heart disease are prone to the development of mild to severe tricuspid regurgitation with or without accompanying tricuspid stenosis.
Suma Pusapati +2 more
semanticscholar +1 more source
Background: Patients with carcinoid heart disease are prone to the development of mild to severe tricuspid regurgitation with or without accompanying tricuspid stenosis.
Suma Pusapati +2 more
semanticscholar +1 more source
Endocrinology and Metabolism Clinics of North America, 2018
Carcinoid heart disease remains a major cause of morbidity and mortality among patients with carcinoid syndrome and metastatic neuroendocrine tumors. Screening of all patients with N-terminal pro-B-type natriuretic peptide and transthoracic echocardiography is critical for early detection, as early symptoms and signs have low sensitivity for the ...
Martyn Caplin +2 more
openaire +3 more sources
Carcinoid heart disease remains a major cause of morbidity and mortality among patients with carcinoid syndrome and metastatic neuroendocrine tumors. Screening of all patients with N-terminal pro-B-type natriuretic peptide and transthoracic echocardiography is critical for early detection, as early symptoms and signs have low sensitivity for the ...
Martyn Caplin +2 more
openaire +3 more sources
Clinical manifestation of neuroendocrine tumor – carcinoid heart disease
Medical alphabet, 2023Carcinoid heart disease (CHD) is a rare manifestation of the carcinoid syndrome, but eventually occurs in most patients and is a major cause of cardiovascular mortality.
F. R. Akildzhonov +6 more
semanticscholar +1 more source
Carcinoid Heart Disease: A Rare Complication of Metastatic Neuroendocrine Tumor
Pakistan Journal of Medical & Health Sciences, 2023Background: Carcinoid heart disease (CHD) is a rare but severe complication of metastatic neuroendocrine tumors (NETs), primarily affecting the right-sided heart valves due to prolonged exposure to vasoactive substances such as serotonin. Objective: This
A. Qasim +5 more
semanticscholar +1 more source